Recently, Nabi et al. [119] developed chitosan NPs conjugated with Tf for the delivery of riluzole, which is used to treat amyotrophic lateral sclerosis, and demonstrated the enhanced brain delivery of Tf-conjugated NPs in comparison to the NPs without the ligand. The gene discussed is TF; the disease is amyotrophic lateral sclerosis.